Australia's most trusted
source of pharma news
Tuesday, 04 November 2025
Posted 3 November 2025 PM
Two pharma giants are fighting ugly for relevance in the exploding weight loss market with Pfizer, seeking to get a foothold, suing to prevent being outbid by a Novo Nordisk trying to avoid watching its grasp on market dominance slipping away.
Pfizer has launched legal action to stop Novo Nordisk from outbidding it in acquiring Metsera, a new biotech with a raft of next generation obesity medicines that have performed well in trials.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.